Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients 07/11/2022 INTERVENTIONAL unchanged 1,507.85 0 Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer 07/13/2022 INTERVENTIONAL unchanged 1,505.85 0 Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies 07/14/2022 INTERVENTIONAL unchanged 1,504.85 0 Postpartum Vaginal Estrogen for Breastfeeding Patients 07/14/2022 INTERVENTIONAL unchanged 1,504.85 0 RCT of Pain Perception With Fast and Slow Tenaculum Application 07/14/2022 INTERVENTIONAL unchanged 1,504.85 0 The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment 07/14/2022 INTERVENTIONAL unchanged 1,504.85 0 A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy 07/15/2022 INTERVENTIONAL unchanged 1,503.85 0 Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer 07/15/2022 INTERVENTIONAL unchanged 1,503.85 0 First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer 07/15/2022 INTERVENTIONAL unchanged 1,503.85 0 Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study) 07/15/2022 OBSERVATIONAL unchanged 1,503.85 0 Fetal Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia 07/18/2022 INTERVENTIONAL unchanged 1,500.85 0 Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment. 07/18/2022 INTERVENTIONAL unchanged 1,500.85 0 Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy 07/18/2022 INTERVENTIONAL unchanged 1,500.85 0 Preoperative Irradiation for Stage I Breast Cancer 07/19/2022 INTERVENTIONAL unchanged 1,499.85 0 Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer 07/19/2022 INTERVENTIONAL unchanged 1,499.85 0 Visualizing Vascular Mechanisms of Lipedema 07/19/2022 OBSERVATIONAL unchanged 1,499.85 0 Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) 07/19/2022 INTERVENTIONAL unchanged 1,499.85 0 Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer 07/20/2022 OBSERVATIONAL unchanged 1,498.85 0 Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers 07/20/2022 INTERVENTIONAL unchanged 1,498.85 0 Enhancing PrEP Outcomes Among Kenyan Adolescent Girls and Young Women With a Novel Pharmacy-based PrEP Delivery Platform 07/20/2022 INTERVENTIONAL unchanged 1,498.85 0 Feasibility of [11C]Acetate-PET in LAM and TSC 07/20/2022 INTERVENTIONAL unchanged 1,498.85 0 Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer 07/20/2022 INTERVENTIONAL unchanged 1,498.85 0 Lymphedema After Gyneco-oncologic Treatment 07/22/2022 INTERVENTIONAL unchanged 1,496.85 0 Comparing Two Prophylactic Antibiotic Protocols in Women With Term Prolonged Pre-labor Rupture of Membrane and Preterm Labor 07/22/2022 INTERVENTIONAL unchanged 1,496.85 0 Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy 07/25/2022 INTERVENTIONAL unchanged 1,493.85 0 Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle. 07/25/2022 OBSERVATIONAL unchanged 1,493.85 0 Enhancing Capacity in Churches to Implement PA Programs 07/26/2022 INTERVENTIONAL unchanged 1,492.85 0 A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor 07/26/2022 INTERVENTIONAL unchanged 1,492.85 0 Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer 07/27/2022 INTERVENTIONAL unchanged 1,491.85 0 Comparison of the Efficacy of Different Treatment Methods in Patients With Carpal Tunnel Syndrome 07/27/2022 INTERVENTIONAL unchanged 1,491.85 0 A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease 07/28/2022 INTERVENTIONAL unchanged 1,490.85 0 Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract 07/28/2022 INTERVENTIONAL unchanged 1,490.85 0 Neoadjuvant Radiation in Locally Advanced Breast Cancer 07/29/2022 INTERVENTIONAL unchanged 1,489.85 0 Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI 07/29/2022 INTERVENTIONAL unchanged 1,489.85 0 Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes 08/01/2022 INTERVENTIONAL unchanged 1,486.85 0 Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care 08/02/2022 INTERVENTIONAL unchanged 1,485.85 0 Accountability for Care Through Undoing Racism & Equity for Moms 08/02/2022 INTERVENTIONAL unchanged 1,485.85 0 Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss 08/02/2022 INTERVENTIONAL unchanged 1,485.85 0 The Maternal Well-Being Study 08/02/2022 INTERVENTIONAL unchanged 1,485.85 0 Clinical Outcomes of Pregnant Individuals With Epilepsy - Prospective Study 08/03/2022 OBSERVATIONAL unchanged 1,484.85 0 Perinatal Mental Health Study (PMHS) India 08/03/2022 OBSERVATIONAL unchanged 1,484.85 0 Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer 08/03/2022 INTERVENTIONAL unchanged 1,484.85 0 Treatment for Antepartum Posttraumatic Stress Disorder/PTSD Study 08/04/2022 INTERVENTIONAL unchanged 1,483.85 0 Letrozole in Preventing Recurrence of Endometrioma Following Laparoscopic Ovarian Cystectomy 08/04/2022 INTERVENTIONAL unchanged 1,483.85 0 A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) 08/04/2022 INTERVENTIONAL unchanged 1,483.85 0 Oxytocin Pharmacokinetics and Pharmacodynamics 08/04/2022 INTERVENTIONAL unchanged 1,483.85 0 A Study of Tumor Imaging With Multispectral Optoacoustic Tomography 08/04/2022 OBSERVATIONAL unchanged 1,483.85 0 The Effect of Nonstress Test Device Noise Level on Stress Parameters in Primiparous Pregnant Women 08/04/2022 OBSERVATIONAL unchanged 1,483.85 0 Effect of Exercise Training on Breastmilk Composition 08/05/2022 INTERVENTIONAL unchanged 1,482.85 0 Early Psychological Intervention After Rape 08/05/2022 INTERVENTIONAL unchanged 1,482.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology